Literature DB >> 16981239

Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice.

D Cruz-Topete1, T Iwaki, V A Ploplis, F J Castellino.   

Abstract

Severe inflammation leads to haemostatic abnormalities, such as the development of microvascular thrombi. As a result, ischaemia-related downstream organ damage can occur. The present study demonstrates that mice with a total deficiency of fibrinogen (Fg(-/-)) present with altered responses to challenge with Gram-negative lipopolysaccharide (LPS). Early survival in response to continuous LPS challenge was increased in Fg(-/-) mice and histological findings indicated that this improvement correlated with a lack of fibrin deposition in organs. Neutrophils appeared early in the lungs of challenged wild-type (WT) mice, but occurred in Fg(-/-) mice at later times. This delayed response in Fg(-/-) mice was confirmed by studies that showed a strong dependence on Fg of binding of neutrophils to endothelial cells in the presence of LPS. While cytokines were also elevated in both WT and Fg(-/-) mice, their levels were generally lower at early times in this latter group. The time course of MIP-2 expression correlated with the occurrence of pulmonary leakage after LPS challenge, which was delayed in Fg(-/-) mice. These results suggest that fibrin(ogen) plays a role as an early mediator in the cross-talk between coagulation and inflammation. Copyright 2006 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981239     DOI: 10.1002/path.2060

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

Review 1.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

2.  Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.

Authors:  Ilse Jongerius; Maren von Köckritz-Blickwede; Malcolm J Horsburgh; Maartje Ruyken; Victor Nizet; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2012-02-07       Impact factor: 7.349

3.  Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence.

Authors:  Ya-Ping Ko; Xiaowen Liang; C Wayne Smith; Jay L Degen; Magnus Höök
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

4.  Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling.

Authors:  Sarah J McMillan; Ritu S Sharma; Emma J McKenzie; Hannah E Richards; Jiquan Zhang; Alan Prescott; Paul R Crocker
Journal:  Blood       Date:  2013-01-11       Impact factor: 22.113

Review 5.  The current status of biomarkers for predicting toxicity.

Authors:  Sarah Campion; Jiri Aubrecht; Kim Boekelheide; David W Brewster; Vishal S Vaidya; Linnea Anderson; Deborah Burt; Edward Dere; Kathleen Hwang; Sara Pacheco; Janani Saikumar; Shelli Schomaker; Mark Sigman; Federico Goodsaid
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-08-21       Impact factor: 4.481

6.  ICAM-1-expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia.

Authors:  Abigail Woodfin; Martina Beyrau; Mathieu-Benoit Voisin; Bin Ma; James R Whiteford; Peter L Hordijk; Nancy Hogg; Sussan Nourshargh
Journal:  Blood       Date:  2015-12-08       Impact factor: 22.113

7.  The effect of evolving trauma care on the development of multiple organ dysfunction syndrome.

Authors:  K J P van Wessem; L P H Leenen
Journal:  Eur J Trauma Emerg Surg       Date:  2014-03-16       Impact factor: 3.693

8.  Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury.

Authors:  Amrendra Kumar Ajay; Janani Saikumar; Vanesa Bijol; Vishal S Vaidya
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

9.  A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase.

Authors:  Luo Wen-Jing; Pu Chuan-Qiang; Li Hong-Hua; Lu Xiang-Hui; Liu Jie-Xiao
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

10.  The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.

Authors:  Devorah Gur-Wahnon; Tehila Mizrachi; Florence-Yehudith Maaravi-Pinto; Athanasis Lourbopoulos; Nikolaos Grigoriadis; Abd-Al Roof Higazi; Talma Brenner
Journal:  J Neuroinflammation       Date:  2013-10-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.